Literature DB >> 16045542

Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma.

Flavia R R Mangone1, M Mitzi Brentani, Suely Nonogaki, Maria Dirlei F S Begnami, Antonio Hugo J F M Campos, Fernando Walder, Marcos B Carvalho, Fernando A Soares, Humberto Torloni, Luiz P Kowalski, Miriam H H Federico.   

Abstract

The activating protein-1 (AP-1) family of transcription factors has been implicated in the control of proliferation and differentiation of keratinocytes, but its role in malignant transformation is not clear. The aim of this study is to assess the pattern of mRNA expression of jun-fos AP-1 family members in 45 samples of head and neck squamous cell carcinomas (HNSCC) and matched adjacent mucosa by means of Northern blot analysis. Transcripts of all family members were identified, except for JunB that was detected only by means of reverse transcription polymerase chain reaction. Neither c-Fos nor JunD or FosB mRNA differed between tumours and normal tissues. We observed a strong Fos-related antigen-1 (Fra-1) and Fra-2 expression, but only Fra-1 mRNA densitometric values were higher in tumour, compared to normal adjacent mucosa (t-test, P = 0.006). A direct relationship between the positive expression of Fra-1 mRNA, above tumour median, was associated with the presence of compromised lymph nodes (Fischer exact test, P = 0.006). In addition, Fra-1 protein staining was assessed in a collection of 180 tumours and 29 histologically normal samples adjacent to tumours in a tissue array. Weak reactivity, restricted to the basal cell layer, was detected in 79% of tumour adjacent normal tissues, opposed to the intense reactivity of cancer tissues. In the subgroup of oral cancers, we have observed a shift in Fra-1 immunoreactivity, as long as the number of patients in each category, cytoplasmic or nuclear/cytoplasmic staining, was analysed (Fischer exact test, P = 0.0005). Thus, Fra-1 gene induction and accumulation of Fra-1 protein may contribute to the neoplastic phenotype in HNSCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16045542      PMCID: PMC2517431          DOI: 10.1111/j.0959-9673.2005.00423.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  29 in total

1.  Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.

Authors:  P O-Charoenrat; P H Rhys-Evans; S A Eccles
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-07

2.  Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.

Authors:  D A Zajchowski; M F Bartholdi; Y Gong; L Webster; H L Liu; A Munishkin; C Beauheim; S Harvey; S P Ethier; P H Johnson
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

3.  Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer.

Authors:  R P Takes; R J Baatenburg de Jong; K Wijffels; E Schuuring; S V Litvinov; J Hermans; J H van Krieken
Journal:  J Pathol       Date:  2001-07       Impact factor: 7.996

4.  FRA-1 expression in hyperplastic and neoplastic thyroid diseases.

Authors:  G Chiappetta; G Tallini; M C De Biasio; F Pentimalli; F de Nigris; S Losito; M Fedele; S Battista; P Verde; M Santoro; A Fusco
Journal:  Clin Cancer Res       Date:  2000-11       Impact factor: 12.531

5.  Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines.

Authors:  F G Ondrey; G Dong; J Sunwoo; Z Chen; J S Wolf; C V Crowl-Bancroft; N Mukaida; C Van Waes
Journal:  Mol Carcinog       Date:  1999-10       Impact factor: 4.784

Review 6.  Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme.

Authors:  B W Ozanne; L McGarry; H J Spence; I Johnston; J Winnie; L Meagher; G Stapleton
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

7.  Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators.

Authors:  A M Bamberger; K Milde-Langosch; E Rössing; C Goemann; T Löning
Journal:  J Cancer Res Clin Oncol       Date:  2001-09       Impact factor: 4.553

Review 8.  Matrix metalloproteinases in squamous cell carcinoma.

Authors:  N Johansson; V M Kähäri
Journal:  Histol Histopathol       Date:  2000-01       Impact factor: 2.303

9.  Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.

Authors:  Y C Hu; K Y Lam; S Law; J Wong; G Srivastava
Journal:  Clin Cancer Res       Date:  2001-08       Impact factor: 12.531

10.  Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa.

Authors:  F S Pasini; M M Brentani; L P Kowalski; M H Federico
Journal:  Head Neck       Date:  2001-09       Impact factor: 3.147

View more
  13 in total

Review 1.  Expression and function of FRA1 protein in tumors.

Authors:  Xiaoyan Jiang; Hui Xie; Yingyu Dou; Jing Yuan; Da Zeng; Songshu Xiao
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

2.  Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.

Authors:  Suely Nonogaki; Heloisa G A Campos; Ossamu Butugan; Fernando A Soares; Flávia Regina Rotea Mangone; Humberto Torloni; M Mitzi Brentani
Journal:  Exp Ther Med       Date:  2010-08-26       Impact factor: 2.447

3.  A miR-34a-SIRT6 axis in the squamous cell differentiation network.

Authors:  Karine Lefort; Yang Brooks; Paola Ostano; Muriel Cario-André; Valérie Calpini; Juan Guinea-Viniegra; Andrea Albinger-Hegyi; Wolfram Hoetzenecker; Ingrid Kolfschoten; Erwin F Wagner; Sabine Werner; Gian Paolo Dotto
Journal:  EMBO J       Date:  2013-07-16       Impact factor: 11.598

4.  Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.

Authors:  Nezar Noor Al-Hebshi; Shiyong Li; Akram Thabet Nasher; Maged El-Setouhy; Rashad Alsanosi; Jan Blancato; Christopher Loffredo
Journal:  Int J Cancer       Date:  2016-03-18       Impact factor: 7.396

5.  Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis.

Authors:  Xiangming Ding; Hongya Pan; Jiong Li; Qi Zhong; Xiaohong Chen; Sarah M Dry; Cun-Yu Wang
Journal:  Sci Signal       Date:  2013-04-30       Impact factor: 8.192

Review 6.  Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer.

Authors:  Laura C Kelley; Sohrab Shahab; Scott A Weed
Journal:  Clin Exp Metastasis       Date:  2008-03-07       Impact factor: 5.150

7.  Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma.

Authors:  Angela Flavia Logullo; Mônica Maria Ágata Stiepcich; Cintia Aparecida Bueno de Toledo Osório; Sueli Nonogaki; Fátima Solange Pasini; Rafael Malagoli Rocha; Fernando Augusto Soares; Maria M Brentani
Journal:  Histopathology       Date:  2011-03-03       Impact factor: 5.087

8.  An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy.

Authors:  Yuhua Song; Santai Song; Dong Zhang; Yan Zhang; Liyong Chen; Lu Qian; Ming Shi; Huibin Zhao; Zefei Jiang; Ning Guo
Journal:  BMC Cancer       Date:  2006-12-28       Impact factor: 4.430

9.  Prognostic value from integrative analysis of transcription factors c-Jun and Fra-1 in oral squamous cell carcinoma: a multicenter cohort study.

Authors:  Hao Xu; Xin Jin; Yao Yuan; Peng Deng; Lu Jiang; Xin Zeng; Xiao-Song Li; Zhi-Yong Wang; Qian-Ming Chen
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

10.  FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.

Authors:  Xiaoling Zhang; Joseph Wu; Suju Luo; Terry Lechler; Jennifer Y Zhang
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.